Literature DB >> 1595707

Effect of glycine and hypertrophy on renal outer medullary hypoxic injury in ischemia reflow and contrast nephropathy.

S N Heyman1, M Brezis, F H Epstein, K Spokes, S Rosen.   

Abstract

Glycine preserves tubular cell integrity under hypoxic and toxic conditions in vitro. It also ameliorates cisplatin nephrotoxicity in vivo. We studied the effect of glycine on tubular necrosis from ischemia reflow and on inner stripe injury in an animal model of radiocontrast nephropathy. In all experiments, glycine (75 mg/100 g/h) increased tubular damage in the inner stripe. In the model of radiocontrast nephropathy, the percentage of medullary thick ascending limb (mTAL) necrosis at 24 hours increased from 22% +/- 6% to 41% +/- 9% or 55% +/- 7% with glycine infusion of 75 or 135 minutes, respectively (mean +/- SE, P less than 0.05, analysis of variance [ANOVA]). Renal function was not significantly affected. In rat kidneys subjected to ischemia reflow, mTAL injury following glycine increased from 1% +/- 0% to 12% +/- 6% (P less than 0.05) and from 8% +/- 5% to 49% +/- 8% (P less than 0.01) 24 hours after 30 minutes and 45 minutes ischemia, respectively. Tubular injury in the inner stripe was maximal in the deep interbundle zone, typical of hypoxic, rather than reperfusion, injury. Prior uninephrectomy increased inner stripe damage, but protected the proximal tubules. Both uninephrectomy and glycine infusion were found to contribute to mTAL necrosis. The infusion of glycine for 1 hour in intact rats increased renal blood flow by 44% and tripled urine volume (P less than 0.01). A parallel increase in glomerular filtration rate GFR; by 22% over 90 minutes) fell short of statistical significance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595707     DOI: 10.1016/s0272-6386(12)80838-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  Changes in intrarenal oxygenation as evaluated by BOLD MRI in a rat kidney model for radiocontrast nephropathy.

Authors:  P V Prasad; A Priatna; K Spokes; F H Epstein
Journal:  J Magn Reson Imaging       Date:  2001-05       Impact factor: 4.813

Review 2.  The role of glycine in regulated cell death.

Authors:  Joel M Weinberg; Anja Bienholz; M A Venkatachalam
Journal:  Cell Mol Life Sci       Date:  2016-04-11       Impact factor: 9.261

Review 3.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection.

Authors:  Holger Scholz; Felix J Boivin; Kai M Schmidt-Ott; Sebastian Bachmann; Kai-Uwe Eckardt; Ute I Scholl; Pontus B Persson
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

5.  Glycine aggravates ischemia reperfusion-induced acute kidney injury through N-Methyl-D-Aspartate receptor activation in rats.

Authors:  Shiyana Arora; Tajpreet Kaur; Anudeep Kaur; Amrit Pal Singh
Journal:  Mol Cell Biochem       Date:  2014-04-17       Impact factor: 3.396

6.  Hypertension and impaired glycine handling in mice lacking the orphan transporter XT2.

Authors:  Hui Quan; Krairerk Athirakul; William C Wetsel; Gonzalo E Torres; Robert Stevens; Y T Chen; Thomas M Coffman; Marc G Caron
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

7.  NFAT5 is protective against ischemic acute kidney injury.

Authors:  Shoujin Hao; Lars Bellner; Hong Zhao; Brian B Ratliff; Zbigniew Darzynkiewicz; Carlos P Vio; Nicholas R Ferreri
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

Review 8.  Why is diabetes mellitus a risk factor for contrast-induced nephropathy?

Authors:  Samuel N Heyman; Christian Rosenberger; Seymour Rosen; Mogher Khamaisi
Journal:  Biomed Res Int       Date:  2013-11-21       Impact factor: 3.411

9.  HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

Authors:  Steffen P Luntz; Kristina Unnebrink; Monika Seibert-Grafe; Hartwig Bunzendahl; Thomas W Kraus; Markus W Büchler; Ernst Klar; Peter Schemmer
Journal:  BMC Surg       Date:  2005-08-17       Impact factor: 2.102

10.  Section 1: Introduction and Methodology.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.